Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of BAT8008 for Injection

NCT05620017 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

182

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: BAT8008 for Injection

Sponsor

Bio-Thera Solutions